AU4334985A – Heterocyclic substituted dihydropyridines
– Google Patents
AU4334985A – Heterocyclic substituted dihydropyridines
– Google Patents
Heterocyclic substituted dihydropyridines
Info
Publication number
AU4334985A
AU4334985A
AU43349/85A
AU4334985A
AU4334985A
AU 4334985 A
AU4334985 A
AU 4334985A
AU 43349/85 A
AU43349/85 A
AU 43349/85A
AU 4334985 A
AU4334985 A
AU 4334985A
AU 4334985 A
AU4334985 A
AU 4334985A
Authority
AU
Australia
Prior art keywords
heterocyclic substituted
substituted dihydropyridines
dihydropyridines
heterocyclic
substituted
Prior art date
1984-06-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU43349/85A
Other versions
AU556496B2
(en
Inventor
David Alker
Simon Fraser Campbell
Peter Edward Cross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1984-06-07
Filing date
1985-06-06
Publication date
1985-12-12
1984-06-07
Priority claimed from GB848414520A
external-priority
patent/GB8414520D0/en
1985-04-03
Priority claimed from GB858508736A
external-priority
patent/GB8508736D0/en
1985-06-06
Application filed by Pfizer Corp, Pfizer Inc
filed
Critical
Pfizer Corp
1985-12-12
Publication of AU4334985A
publication
Critical
patent/AU4334985A/en
1986-11-06
Application granted
granted
Critical
1986-11-06
Publication of AU556496B2
publication
Critical
patent/AU556496B2/en
2005-06-06
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
125000004925
dihydropyridyl group
Chemical group
N1(CC=CC=C1)*
0.000
title
1
125000000623
heterocyclic group
Chemical group
0.000
title
1
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/08—Vasodilators for multiple indications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/12—Antihypertensives
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
AU43349/85A
1984-06-07
1985-06-06
Heterocyclic substituted dihydropyridines
Ceased
AU556496B2
(en)
Applications Claiming Priority (4)
Application Number
Priority Date
Filing Date
Title
GB848414520A
GB8414520D0
(en)
1984-06-07
1984-06-07
Dihydropyridines
GB8414520
1984-06-07
GB8508736
1985-04-03
GB858508736A
GB8508736D0
(en)
1985-04-03
1985-04-03
Dihydropyridines
Publications (2)
Publication Number
Publication Date
AU4334985A
true
AU4334985A
(en)
1985-12-12
AU556496B2
AU556496B2
(en)
1986-11-06
Family
ID=26287832
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU43349/85A
Ceased
AU556496B2
(en)
1984-06-07
1985-06-06
Heterocyclic substituted dihydropyridines
Country Status (14)
Country
Link
US
(1)
US4618609A
(en)
EP
(1)
EP0164247B1
(en)
JP
(1)
JPH0641464B2
(en)
AU
(1)
AU556496B2
(en)
DE
(1)
DE3567460D1
(en)
DK
(1)
DK170402B1
(en)
ES
(1)
ES8700857A1
(en)
FI
(1)
FI852222L
(en)
GR
(1)
GR851383B
(en)
HU
(1)
HUT41404A
(en)
IE
(1)
IE57816B1
(en)
IL
(1)
IL75411A0
(en)
PL
(1)
PL253821A1
(en)
PT
(1)
PT80597B
(en)
Families Citing this family (12)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB8412208D0
(en)
*
1984-05-12
1984-06-20
Pfizer Ltd
Quinolone inotropic agents
WO1987000836A1
(en)
*
1985-08-06
1987-02-12
Boehringer Biochemia Robin S.P.A.
Pharmaceutically active 2-thiomethyl-substituted-1,4-dihydropyridines
GB8527698D0
(en)
*
1985-11-09
1985-12-11
Pfizer Ltd
Dihydropyridine antiischaemic & antihypertensive agents
US4761420A
(en)
*
1986-06-13
1988-08-02
Laboratoires Syntex S.A.
Antihypertensive dihydropyridine derivatives
US4920134A
(en)
*
1987-08-07
1990-04-24
Takeda Chemical Industries, Ltd.
2-O-pyrimidinyl glycerol derivatives
US5691360A
(en)
*
1993-12-08
1997-11-25
Alcon Laboratories, Inc.
Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
US5424321A
(en)
*
1993-12-08
1995-06-13
Alcon Laboratories, Inc.
Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
SI2384753T1
(en)
*
2003-08-29
2016-06-30
The Brigham And Women’s Hospital, Inc.
Hydantoin derivatives as inhibitors of cellular necrosis
WO2010075290A1
(en)
*
2008-12-22
2010-07-01
President And Fellows Of Harvard College
Unsaturated heterocyclic inhibitors of necroptosis
EP2381775A4
(en)
2008-12-23
2012-08-15
Harvard College
Small molecule inhibitors of necroptosis
EP2968276A4
(en)
2013-03-15
2017-02-15
President and Fellows of Harvard College
Hybrid necroptosis inhibitors
KR20170123607A
(en)
2014-12-11
2017-11-08
프레지던트 앤드 펠로우즈 오브 하바드 칼리지
Cell Necrosis Inhibitors and Related Methods
Family Cites Families (4)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE2951945A1
(en)
*
1979-12-22
1981-07-02
Ibm Deutschland Gmbh, 7000 Stuttgart
CIRCUIT ARRANGEMENT FOR CAPACITIVE READING SIGNAL AMPLIFICATION IN AN INTEGRATED SEMICONDUCTOR STORAGE WITH AN INTEGRATED SEMICONDUCTOR STORAGE WITH STORAGE CELLS IN MTL TECHNOLOGY
EP0100189B1
(en)
*
1982-07-22
1986-05-28
Pfizer Limited
Dihydropyridine anti-ischaemic and antihypertensive agents
PL140069B1
(en)
*
1982-12-21
1987-03-31
Pfizer
Method of obtaining new derivatives of dihydropiridine
US4515799A
(en)
*
1983-02-02
1985-05-07
Pfizer Inc.
Dihydropyridine anti-ischaemic and antihypertensive agents
1985
1985-05-29
EP
EP85303765A
patent/EP0164247B1/en
not_active
Expired
1985-05-29
DE
DE8585303765T
patent/DE3567460D1/en
not_active
Expired
1985-05-31
JP
JP60118702A
patent/JPH0641464B2/en
not_active
Expired – Lifetime
1985-06-03
FI
FI852222A
patent/FI852222L/en
not_active
Application Discontinuation
1985-06-05
IL
IL75411A
patent/IL75411A0/en
unknown
1985-06-05
PT
PT80597A
patent/PT80597B/en
not_active
IP Right Cessation
1985-06-05
US
US06/741,339
patent/US4618609A/en
not_active
Expired – Lifetime
1985-06-05
PL
PL25382185A
patent/PL253821A1/en
unknown
1985-06-06
GR
GR851383A
patent/GR851383B/el
unknown
1985-06-06
DK
DK253785A
patent/DK170402B1/en
not_active
IP Right Cessation
1985-06-06
HU
HU852246A
patent/HUT41404A/en
unknown
1985-06-06
IE
IE1417/85A
patent/IE57816B1/en
unknown
1985-06-06
AU
AU43349/85A
patent/AU556496B2/en
not_active
Ceased
1985-06-07
ES
ES543999A
patent/ES8700857A1/en
not_active
Expired
Also Published As
Publication number
Publication date
FI852222A0
(en)
1985-06-03
AU556496B2
(en)
1986-11-06
PT80597A
(en)
1985-07-01
EP0164247A1
(en)
1985-12-11
IE851417L
(en)
1985-12-07
ES8700857A1
(en)
1986-11-16
DK253785A
(en)
1985-12-08
IE57816B1
(en)
1993-04-21
JPS611685A
(en)
1986-01-07
JPH0641464B2
(en)
1994-06-01
FI852222L
(en)
1985-12-08
DK170402B1
(en)
1995-08-21
EP0164247B1
(en)
1989-01-11
ES543999A0
(en)
1986-11-16
GR851383B
(en)
1985-11-25
US4618609A
(en)
1986-10-21
PT80597B
(en)
1987-04-23
DK253785D0
(en)
1985-06-06
DE3567460D1
(en)
1989-02-16
PL253821A1
(en)
1986-07-01
IL75411A0
(en)
1985-10-31
HUT41404A
(en)
1987-04-28
Similar Documents
Publication
Publication Date
Title
AU579132B2
(en)
1988-11-17
Heterocyclic compounds
AU570812B2
(en)
1988-03-24
Tetrahydrophthalimides
AU5111485A
(en)
1986-06-19
Trisubstituted piperidine derivatives
AU4982185A
(en)
1986-05-22
Novel 5-amino-4-hydroxyvaleryl derivatives
AU4263685A
(en)
1985-11-21
Ammotetralin derivatives
AU4325485A
(en)
1985-12-05
Aminoalkylphenoxy derivatives
AU572699B2
(en)
1988-05-12
Piperidine derivatives
AU576924B2
(en)
1988-09-08
2-piperizino-pteridine derivatives
AU571721B2
(en)
1988-04-21
Substituted propargyloxyacetonitrile derivatives
AU577912B2
(en)
1988-10-06
Aminoacyllabdane derivatives
AU556496B2
(en)
1986-11-06
Heterocyclic substituted dihydropyridines
AU4086885A
(en)
1985-10-17
Hydroxy-4-2h-1-benzothiopyran-2-one derivatives
AU4343885A
(en)
1985-12-12
Indole – tetrahydropyridyl derivatives
AU3797485A
(en)
1985-08-01
Azolyl-aryl-alkanol derivatives
AU554571B2
(en)
1986-08-28
Heterocyclic substituted dihydropyridine cardiovascular agents
AU554078B2
(en)
1986-08-07
Peptide-substituted heterocyclic immunostimulants
AU4508085A
(en)
1986-01-23
2-phenyl-4-piperidyl quinoline derivatives
AU4168885A
(en)
1985-10-31
Chartreusin derivatives
AU4145285A
(en)
1985-10-24
Tetrahydroquinolin-1-yl- carbonylimidazole derivatives
AU4682785A
(en)
1986-03-06
Dihydropyridine derivatives
AU4005885A
(en)
1985-09-26
2-oxindole-1-carboxamide derivatives
GB2162177B
(en)
1987-09-03
Glutarimide derivatives
AU4106085A
(en)
1985-10-17
2 – oxoindole derivatives
AU583062B2
(en)
1989-04-20
Heterocyclic amides
AU4045585A
(en)
1986-01-30
Sulphamoylguanidine derivatives
None